Abstract
Periprosthetic hip dislocation is a frequent complication after primary total hip arthroplasty. Observational studies suggest that dual mobility cups may reduce dislocation risk to approximately 1%, but definitive randomized evidence supporting their routine use in primary total hip arthroplasty is absent.
The REDEP trial is the first prospective, randomized controlled trial that compares dual mobility cups with unipolar cups in patients ≥70 years who electively undergo primary total hip arthroplasty via a posterolateral approach. The primary objective of the trial is to determine the difference in the number of patients who suffer a periprosthetic dislocation of the hip within 1 year after primary total hip arthroplasty in this population. Other outcomes include the difference in the total number of hip dislocations (including recurrent dislocations within patients), differences in patient-reported outcome measures, and differences in the incidence of (serious) adverse events.
This statistical analysis plan describes the primary statistical analysis for the REDEP study. The analyses described herein were defined prior to database lock and unblinding. Secondary analyses will be described in subsequent versions of this statistical analysis plan.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT04031820
Clinical Protocols
https://www.medrxiv.org/content/10.64898/2026.08.18.26360681v2
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All statistical analyses described in the statistical analysis plan will be reported in a manuscript and will be published in a scientific journal with open access.
List of Abbreviations
- Abbreviation
- Definition
- AE
- Adverse Event
- ASA
- American Society of Anaesthesiology classification
- AT
- As Treated
- BMI
- Body Mass Index
- CI
- Confidence Interval
- CONSORT
- Consolidated Standards of Reporting Trials
- EQ-5D
- EuroQol 5 Dimensions
- HOOS-PS
- Hip disability and Osteoarthritis Outcome Score Physical Short form
- ICH
- International Conference on Harmonisation
- IQR
- Interquartile range
- ITT
- Intention To Treat
- LROI
- Landelijke Registratie Orthopedische Interventies (Dutch Arthroplasty Register)
- NRS
- Numeric Rating Scale
- OR
- Odds Ratio
- PP
- Per Protocol
- PROM
- Patient Reported Outcome Measure
- QALY
- Quality Adjusted Life Year
- SAE
- Serious Adverse Event
- SAP
- Statistical Analysis Plan
- SD
- Standard Deviation
- THA
- Total Hip Arthroplasty
- WMO
- Wet Medisch-wetenschappelijk Onderzoek met Mensen





